Click a topic below for an index of articles:

 

New-Material

Home

Alternative-Treatments

Financial or Socio-Economic Issues

Forum

Health Insurance

Hepatitis

HIV/AIDS

Institutional Issues

International Reports

Legal Concerns

Math Models or Methods to Predict Trends

Medical Issues

Our Sponsors

Occupational Concerns

Our Board

Religion and infectious diseases

State Governments

Stigma or Discrimination Issues

If you would like to submit an article to this website, email us at info@heart-intl.net for a review of this paper
info@heart-intl.net

 

any words all words
Results per page:

“The only thing necessary for these diseases to the triumph is for good people and governments to do nothing.”


      

Bush To Revoke Exec Order on Intellectual Property Rights and HIV/AIDS Medicines in Africa

http://lists.essential.org/pipermail/ip-health/2001-January/000794.html

Zackie Achmat Zackie Achmat <zackie@pixie.co.za>
Tue, 23 Jan 2001 19:47:00 +0200


This is a multi-part message in MIME format.
 



------=_NextPart_000_0002_01C08576.3516DDA0
Content-Type: text/plain;
        charset="iso-8859-5"
Content-Transfer-Encoding: quoted-printable
 



Dear All
 



Sooner than decency would have allowed an "intelligent politician" but =
then we are all learning that politicians are often not blessed with =
intelligence.
 
    




Regards
 



Zackie Achmat
 



KAISER DAILY HIV/AIDS REPORT
A free service of kaisernetwork.org
http://www.kaisernetwork.org/
 



Bush Reviewing Executive Order Allowing International Importation of =
Generic HIV/AIDS Drugs
 

    

President Bush may reverse former President Clinton's executive order =
that allows sub-Saharan African governments to import generic versions =
of HIV/AIDS medications from other countries where the drugs are =
manufactured while still under U.S. patent, Bloomberg News/Pittsburgh =
Post-Gazette reports. According to drug companies such as =
GlaxoSmithKline, the "world's largest producer of AIDS drugs," as well =
as Merck & Co., Bristol-Myers Squibb Co. and Roche Pharmaceuticals, the =
executive order, signed by Clinton in May, "changed the way their drugs =
are priced" (Rosenkrantz, Bloomberg News/Pittsburgh Post-Gazette, 1/22). =
According to the order, the United States "shall not seek, through =
negotiation or otherwise, the revocation or revision of any intellectual =
property law or policy" of sub-Saharan African countries provided that =
they promote "access to HIV/AIDS pharmaceuticals or medical technologies =
for affected populations in that country." In essence, the order holds =
African countries to the "less stringent standard of a World Trade =
Organization agreement on intellectual property protection," instead of =
U.S. trade laws concerning patents (Kaiser Daily HIV/AIDS Report, =
5/11/00).